Signal active
Bio
Akhil Saklecha focuses on early stage investments with an interest towards medical technology. As a Partner at Artiman, he has led investments in DMS Networks and Cellmax.
Akhil has over 15 years of experience in medicine and healthcare management. Prior to joining Artiman in 2010, Akhil was Medical Director of a 750 bed hospital's regional transfer program. Prior to that position, he was President and CEO of Canton Aultman Emergency Physicians, a professional services firm that provides physicians, mid-level providers, and coding expertise to multiple hospitals and urgent care centers.
He was also Chairman of Emergency Medicine at Aultman Hospital, a large trauma, cardiac, and stroke center seeing nearly 90,000 patients annually. In this same time period, Akhil has served at the local, state, and national levels within emergency medicine, healthcare quality, information technology, managed care, and emergency medical services.
Location
San Francisco, California, United States, North America
Social
Primary Organization
1921
17
6
3
1001-5000
Health Care, Medical, Non Profit, Hospital
Jobs history
1
Cleveland Clinic
Managing Director
2019 - Current
Board and Advisor Roles
1
HomeUnion
Board Member
Invalid date - Current
Invest in regions
Profile Resume
Akhil Saklecha is the Managing Director at Cleveland Clinic, based in United States, North America. With a background in Health Care, Akhil Saklecha has a rich history of leadership and innovation. Akhil Saklecha studied BS Integrated Life Sciences @ Kent State University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
5
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Sep 08, 2014 | HomeUnion | Series A - HomeUnion | Artiman Ventures | 5.5M |
Jul 26, 2016 | CellMax Life | Series A - CellMax Life | Artiman Ventures | 9.0M |
Jun 28, 2018 | ApplyBoard | Series A - ApplyBoard | Artiman Ventures | 13.0M |
May 27, 2019 | ApplyBoard | Series B - ApplyBoard | Artiman Ventures | 40.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity